Recent Advances in Sleep and Circadian Characteristics in Eating Disorders: A Systematic Review of the Last Five Years (2020-2025)
Abstract
Purpose: A high number of people affected by eating disorders also show severe sleep disturbances, as well as circadian rhythm disruptions. However, research is relatively limited, often yielding conflicting results, especially when comparing clinical populations to healthy controls. Few interventions currently integrate sleep and circadian considerations into ED treatment. This review aims to synthesize recent evidence on sleep and circadian alterations in EDs and to identify research and clinical priorities.
Methods: A systematic research through four academic databases was conducted during September 2025, seeking studies on the theme published between 2020-2025. Eligible articles were narratively synthesized to provide a comprehensive and recent overview of the state of the art. Quality appraisal tools were used according to the studies' design.
Results: Eleven studies met inclusion criteria. Sleep disturbances were most consistently reported in individuals with anorexia nervosa, including poor sleep quality. Evidence for bulimia nervosa and binge-eating disorder was limited and inconclusive, since only a study was included. Five case-control studies compared clinical populations to healthy controls and three studies assessed the effects of ED-focused treatments on sleep. Two studies evaluated a sleep-specific intervention, while one employed bright light therapy. Objective sleep measures were rarely employed.
Conclusion: Sleep and circadian disturbances represent an…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.